Fick’s Second Law of Diffusion has long been employed to describe in vitro percutaneous permeation experiments: Numerical solution in percutanous drug absorption Thesis, USM, Malaysia
University | Universiti Sains Malaysia (USM) |
Subject | Numerical solution in percutanous drug absorption Thesis |
- Introduction
Fick’s Second Law of Diffusion has long been employed to describe in vitro percutaneous permeation experiments where the steady state is eventually attained (see [27–29]). When the donor cell concentration, C, is maintained at a constant value, the drug flux per unit area from the donor cell to the receptor cell, through the skin, approaches the steady-state flux, Jss , which is
related to C by the formula
Jss ¼ Kp C;
where Kp is the permeability coefficient. When Fick’s Law prevails, and provided the skin may be regarded as a simple diffusion membrane and the skin–receptor cell-boundary clearance may be assumed to be very large, the permeability coefficient may also be written in the form
Kp ¼ KmDs=Ls; ð2Þ
where Km is the vehicle (donor cell)-skin partition coefficient and Ds is the diffusion coefficient of a drug through the skin which has thickness Ls . Experimental values for Km and Ds for various compounds have been estimated using (1) and (2) in [27–29].
Are You Searching Answer of this Question? Request Malaysian Writers to Write a plagiarism Free Copy for You.
It is only recently, however, that this simple diffusion membrane model has been applied to processes in which a finite dose is applied topically [1,5,8,10,18,20,26,30] as well as to processes after removal [16,17,20,32]. I
n finite-dose processes, two parameters, the diffusion parameter, kd, and the partition parameter, ‘d , [25] (called the apparent length of diffusion in [18]), are employed.
These are defined by
kd ¼ Ds=L2
and
‘d ¼ KmLs;
respectively, and are used in pharmacokinetics when a process approaching the steady state is under consideration. The lag-time, TL , has been estimated to be TL ¼ 1=ð6kdÞ; this estimate was used by Barry [2], Crank [6] and Kubota and Twizell [21]. The parameters kd and ‘d are connected to Kp by the formula
Kp ¼ kd‘d.
Sometimes, in the description of finite-dose percutaneous-absorption kinetics, the diffusivity of a drug in the vehicle, of which the thickness is Lv , is taken to be very large and the skin-receptor cell clearance (or skin-capillary clearance for in vivo conditions) to be very large also [1,5,10,20,26,30]. A few papers describe the diffusion processes of finite doses of a drug, assuming
that the diffusion coefficient of the drug, Dv , through the vehicle has a finite value (see [13,18,19,22]) and that the skin-receptor cell (capillary) clearance per unit area, per unit con- centration excess at the skin surface, CL, also has a finite value [9,13,15–19,32]. When this clearance process is incorporated into the model the normalized skin-capillary clearance, kc , found by the formula
kc ¼ CL=Ls,
partment model [9] are available.
Stuck in Completing this Assignment and feeling stressed ? Take our Private Writing Services.
The repeated topical application of a finite dose of a drug is common practice in dermatology and orthopaedics [3,4]. Even for those drugs which produce systemic effect(s) when applied to the skin, the pharmacokinetics after a repeated dose to the same site are worthy of study [9,19,22,23].
The purpose of this paper is to model the repeated topical application of a drug by partial differential equations (PDEs). These are solved using finite-difference methods which are second-order accurate in space and time [33]. The results of numerical experiments will reveal the effects of the change in the application time (the time interval after the application of the vehicle to the skin until its removal) while the dosing interval (the time between consecutive applications) is fixed. Results relating to a change in the dosing interval with fixed application time are also given.
In addition, comparisons are made of results calculated using the ‘‘random walk method’’, em- ployed by Kubota [14] and Kubota et al. [19] to model the repeated application of a finite dose of a drug to the skin, with results obtained using the finite-difference methods[33].
Get Solution of this Assessment. Hire Experts to solve this assignment for you Before Deadline.
Get Help By Expert
Looking for assignment helper Malaysia or thesis writing services? Look no further! Our team provides top-quality assistance tailored for Malaysia students. From tackling complex topics like Numerical solution in percutaneous drug absorption Thesis to any other subject, our experts are here to help.
Recent Solved Questions
- NBNS3224: Obstetric and Gynaecology Assignment, OUM, Malaysia Madam M, aged 28 years, is a primigravida of 12 weeks gestation. She was admitted to the ward because of threatened
- Project Management Assignment, UTAR, Malaysia You are the project manager for your company’s MCP project. You are collaborating with your project team
- KNC6013: Sustainable Project Management Assignment, USM, Malaysia Sustainable Development Decision Making for sustainable project management can be a very arduous task
- PGBM150: Innovation Entrepreneurship & Technology Transfer Report, SU, Malaysia The assessment has been specifically designed to accommodate the students varying commercial knowledge and understanding of module content
- Occupational Safety and Health Management Report, OUM, malaysia Discuss the tragedy happened in this movie from the point of view of the Domino Theory and Multiple Causation Theory
- Economics Assignment, UITM, Malaysia Economics is the study of how society manages its scarce resources. Discuss the problem of scarcity in Malaysia
- SBFS1103: Thinking Skills And Problem Solving Assignment OUM Malaysia The purpose of the assignment is to expose learners to various problem-solving strategies
- Management & Innovation Report, HWU, Malaysia Prepare a detailed report in terms of identifying the current innovation challenges of the organization
- Accounting and Finance Management Assignment, UM, Malaysia Develop a spreadsheet model and use it to find the project’s NPV, IRR, and payback period. Conduct sensitivity analysis to determine
- European Union Law Course Work, UOL, Malaysia In June 2020, the European Union adopted the ‘consumer protection’ directive. The Directive provides that consumers